Amneal Pharmaceuticals, INC. (AMRX) — DEF 14A Filings

All DEF 14A filings from Amneal Pharmaceuticals, INC.. Browse 2 Proxy Statement reports with AI-powered summaries and risk analysis.

DEF 14A Filings (2)

Amneal Pharma Proxy: Exec Pay & Board Nominee Details — Mar 25, 2025 Risk: medium
Amneal Pharmaceuticals, Inc. filed its definitive proxy statement on March 25, 2025, for its annual meeting on May 6, 2025. The filing details executive compens
Amneal Pharmaceuticals, Inc. Files Definitive Proxy Statement (DEF 14A) — Mar 22, 2024 Risk:
Amneal Pharmaceuticals, Inc. (AMRX) filed a Proxy Statement (DEF 14A) with the SEC on March 22, 2024. Filing Type: DEF 14A (Definitive Proxy Statement). Reporti

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX